Coexpression of ANXA2, SOD2 and HOXA13 predicts poor prognosis of esophageal squamous cell carcinoma

Oncology Reports

Volumn 31, Issue 5, 2014, Pages 2157-2164

  Ma, Ruo Lan ^a   Shen, Lu Yan ^a   Chen, Ke Neng ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

ANXA2; Coexpression; Esophageal squamous cell carcinoma; HOXA13; Prognosis; SOD2

Indexed keywords

MESSENGER RNA; ANXA2 PROTEIN, HUMAN; HOMEOBOX PROTEIN HOXA13; HOMEODOMAIN PROTEIN; LIPOCORTIN 2; MANGANESE SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE; TUMOR MARKER;

ADULT; ANXA2 GENE; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE EXPRESSION; GENE TARGETING; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HOXA13 GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA TRANSLATION; SOD2 GENE; TUMOR GENE; BIOSYNTHESIS; ESOPHAGUS TUMOR; GENETICS; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SQUAMOUS CELL CARCINOMA;

ANNEXIN A2; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RNA, MESSENGER; SUPEROXIDE DISMUTASE; TUMOR MARKERS, BIOLOGICAL;

EID: 84898663115     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3088     Document Type: Article

References (23)

1. Macfarlane GJ and Boyle P: The epidemiology of oesophageal cancer in the UK and other European countries. J R Soc Med 87: 334-337, 1994
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011
3. Chen KN, Gu ZD, Ke Y, Li JY, Shi XT and Xu GW: Expression of 11 HOX genes is deregulated in esophageal squamous cell carcinoma. Clin Cancer Res 11: 1044-1049, 2005
4. Shah N and Sukumar S: The Hox genes and their roles in oncogenesis. Nat Rev Cancer 10: 361-371, 2010
5. Takahashi O, Hamada J, Abe M, et al: Dysregulated expression of HOX and ParaHOX genes in human esophageal squamous cell carcinoma. Oncol Rep 17: 753-760, 2007
6. Gu Z, Shen L, Wang H, et al: HOXA13 promotes cancer cell growth and predicts poor survival of patients with esophageal squamous cell carcinoma. Cancer Res 69: 4969-4973, 2009
7. Shen LY and Chen KN: Exploration of target genes of HOXA13 in esophageal squamous cell carcinoma cell line. Cancer Lett 312: 18-23, 2011
8. Emoto K, Yamada Y, Sawada H, et al: Annexin II overexpression correlates with stromal tenascin-C overexpression: A prognostic marker in colorectal carcinoma. Cancer 92: 1419-1426, 2001
9. Emoto K, Sawada H, Yamada Y, et al: Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma. Anticancer Res 21: 1339-1345, 2001
10. Díaz VM, Hurtado M, Thomson TM, Reventós J and Paciucci R: Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro. Gut 53: 993-1000, 2004
11. Esposito I, Penzel R, Chaib-Harrireche M, et al: Tenascin C and annexin II expression in the process of pancreatic carcinogenesis. J Pathol 208: 673-685, 2006
12. Ji NY, Park MY, Kang YH, et al: Evaluation of annexin II as a potential serum marker for hepatocellular carcinoma using a developed sandwich ELISA method. Int J Mol Med 24: 765-771, 2009
13. Wang CY, Chen CL, Tseng YL, et al: Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms. J Biol Chem 287: 32512-32524, 2012
14. Sharma MR, Koltowski L, Ownbey RT, Tuszynski GP and Sharma MC: Angiogenesis-associated protein annexin II in breast cancer: Selective expression in invasive breast cancer and contribution to tumor invasion and progression. Exp Mol Pathol 81: 146-156, 2006
15. MacMillan-Crow LA and Crow JP: Does more MnSOD mean more hydrogen peroxide? Anticancer Agents Med Chem 11: 178-180, 2011
16. Miriyala S, Holley AK and St Clair DK: Mitochondrial superoxide dismutase - signals of distinction. Anticancer Agents Med Chem 11: 181-190, 2011
17. Nakano T, Oka K and Taniguchi N: Manganese superoxide dismutase expression correlates with p53 status and local recurrence of cervical carcinoma treated with radiation therapy. Cancer Res 56: 2771-2775, 1996
18. Ennen M, Minig V, Grandemange S, et al: Regulation of the high basal expression of the manganese superoxide dismutase gene in aggressive breast cancer cells. Free Radic Biol Med 50: 1771-1779, 2011
19. Toh Y, Kuninaka S, Oshiro T, et al: Overexpression of manganese superoxide dismutase mRNA may correlate with aggressiveness in gastric and colorectal adenocarcinomas. Int J Oncol 17: 107-112, 2000
20. Venkataraman S, Wagner BA, Jiang X, et al: Overexpression of manganese superoxide dismutase promotes the survival of prostate cancer cells exposed to hyperthermia. Free Radic Res 38: 1119-1132, 2004
21. Liu Y, Borchert GL, Donald SP, et al: MnSOD inhibits proline oxidase-induced apoptosis in colorectal cancer cells. Carcinogenesis 26: 1335-1342, 2005
22. Hu H, Luo ML, Du XL, et al: Up-regulated manganese superoxide dismutase expression increases apoptosis resistance in human esophageal squamous cell carcinomas. Chin Med J 120: 2092-2098, 2007
23. Salsi V and Zappavigna V: Hoxd13 and Hoxa13 directly control the expression of the EphA7 Ephrin tyrosine kinase receptor in developing limbs. J Biol Chem 281: 1992-1999, 2005